SCD and metabolic dysfunction-associated steatotic liver disease: Moreover, polyunsaturated fatty acids suppress SREBP-1c, SCD-1, and fatty acid oxidation; a decrease in n-3 polyunsaturated fatty acid level might exacerbate NAFLD [27,28,29].